FDA NDC Directory · JSON-LD · Markdown

Memantine hydrochloride

NDC 68382-548 · HUMAN PRESCRIPTION DRUG · CAPSULE, EXTENDED RELEASE

Labeler / ManufacturerZydus Pharmaceuticals USA Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA203293
Dosage form / routeCAPSULE, EXTENDED RELEASE · ORAL
Active ingredientsMEMANTINE HYDROCHLORIDE (21 mg/1)
Marketing started20180408
Package count3

External sources

Source: openFDA. Public-domain (CC0).